Trials / Conditions / RET Gene Mutation
RET Gene Mutation
4 registered clinical trials studyying RET Gene Mutation — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC NCT06109558 | Hunan Province Tumor Hospital | Phase 1 / Phase 2 |
| Active Not Recruiting | Real-Time Monitoring of Symptoms in Lung Cancer Patients Receiving Oral Targeted Therapies NCT05370469 | University of Virginia | N/A |
| Terminated | Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or M NCT04161391 | Turning Point Therapeutics, Inc. | Phase 1 / Phase 2 |
| Completed | Continued Access to RXDX-105 NCT03784378 | Memorial Sloan Kettering Cancer Center | Phase 1 |